Skip to main content

Table 2 Immunity-related DEGs significantly associated with overall survival

From: Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway

ID

conMean

treatMean

logFC

pValue

ULBP2

0.313465

1.033828

1.72162

2.25E−10

BCL3

10.86832

21.77691

1.002671

7.40E−30

IL18

1.871154

4.372457

1.224516

1.01E−20

NFKBIE

4.064862

8.77383

1.11

7.16E−31

IGHE

0.073772

1.261696

4.096154

7.32E−26

SEMA6D

3.861534

1.204644

− 1.68057

1.06E−50

FGF7

4.864147

1.519639

− 1.67846

2.22E−45

IL22RA1

0.824342

0.403413

− 1.03098

1.60E−24

IL2RG

5.736202

12.19136

1.087691

0.000147

NPR3

6.301688

1.713778

− 1.87856

4.06E−20

SDC1

33.2673

116.7269

1.81096

4.05E−36

TNFRSF8

0.946059

0.421308

− 1.16705

4.83E−31

TRBC2

5.501714

11.98817

1.123659

0.00186

TRBV5-5

0.09757

0.21412

1.133913

0.001259

TRDV1

0.226715

0.616004

1.442061

0.005183

PSME2

17.71725

41.26326

1.219703

2.58E−41